Bevurogant (BI 730357) is a drug which acts as a potent and selective antagonist (or perhaps inverse agonist) of the receptor RAR-related orphan receptor gamma (RORγ). It has anti-inflammatory effects and has been researched for the treatment of various conditions in which inflammation plays a role.
References